We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Policy schedule Sample Clauses

Policy schedule. The summary of the benefits under the policy, the premium due and any special conditions that apply. 2
Policy scheduleThe schedule provided to You when You purchased this Policy, which contains Your details, details of the Insured Vehicle and the Policy term.
Policy schedule. Policy Schedule means the document which specifies the premium amount, details of the Policyholder/You, Contract details, Policy Period, Deductible, Limit of Liability, and attached to and forming part of this Policy.
Policy scheduleOwner and Beneficiary As named in the Application or as later changed. See the Owner and Beneficiary Section of the Policy. Policy Number Age Sex Specimen 35 Male Policy Date Date of Issue Policy Class September 1, 1993 September 1, 1993 Smoker Standard Policy Loan Interest Rate Basis of Values Interest Rate 6% 4.5% Death Benefit Option 1 Schedule of Benefits 30 Payment Variable Life (LIFE) $25,000 Schedule of Annual Premiums Policy Years LIFE First 30 $499.75 Total Premium on Policy Date Annual Semi-Annual Quarterly $499.75 $257.37 $131.18 Table of Net Annual Premiums (Amount Invested; Based on Maximum Premium Charges) Beginning of Policy Year Net Premium First 30 $404.72 Annual Administrative Charge (Reflected in Net Annual Premium) $55.00 Each Net Unscheduled Payment will be equal to the Unscheduled Payment less 9%. Sex-distinct Issue Xxxxxx X. Xxxxxxxxx /s/ Secretary New England Variable Life Insurance Company
Policy scheduleOwner and Beneficiary As named in the Application or as later changed. See the Owner and Beneficiary Section of the Policy. Policy Number Age Sex Specimen 35 Male Policy Date Maturity Date* April 1, 1995 April 1, 2060 Policy Loan Interest Rate 5.5% THIS POLICY IS ADJUSTABLE. IF IT IS ADJUSTED, THIS SECTION 1 WILL BE CHANGED. SEE SECTION 16.
Policy schedule. 3 SECTION 1: DEFINITIONS OF IMPORTANT TERMS............................... 7-12 .
Policy scheduleSchedule I hereof lists for each Policy the following information as of the Plan Effective Date: (a) the policy identification number (“Policy ID”) as reflected in the records of Position Holder Trust, (b) the name of the Insurer (as defined in Exhibit A), (c) the face amount or net death benefit of the Policy, (d) information regarding Beneficial Ownership of the Policy as of the Plan Effective Date, subject to the terms and conditions of the Plan and the Position Holder Trust Agreement, including, (i) the aggregate percentage interest beneficially owned by all Catch-Up Position Holders (and the portion thereof held by Disputing Position Holders), (ii) the aggregate percentage interest beneficially owned by all PPDA Position Holders (and the portion thereof held by Disputing Position Holders), (iii) the aggregate percentage interest beneficially owned by all Continuing Fractional Holders who are neither Catch-Up Position Holders nor PPDA Position Servicing Agreement 2 Holders, (iv) the percentage interest beneficially owned by Position Holder Trust, and (v) the aggregate percentage interest held by the Positon Holder Trust pledged as New XXX Note Collateral (as defined in Exhibit A), and the portion thereof relating to New XXX Notes that may be issued to Disputing Position Holders, (e) the information in the Premium Payment Schedule (as defined in Exhibit A) for such Policy, (f) the date of the most recent premium illustration for the Policy, if applicable, (g) the date of the most recent life expectancy report for the Insured(s) under the Policy, and (h) the aggregate amount of funds included in the Fractional Holders’ Premium Reserve Escrow Account (as defined in Exhibit A) identified with the Policy, if any, as of the Plan Effective Date (on an aggregate basis for all Continuing Fractional Holders). (i) Position Holder Trust is separately providing to Servicer a schedule (the “Policy Insured Schedule”) that lists for each Policy the following information: (x) the Policy ID, (y) the name of, and contact information for, each Insured, and (z) the name of, and contact information for, each other person identified as a potential contact for information relating to the Insured. Servicer shall update the information in Schedule I on a regular, periodic basis as set forth in Schedule XII hereof.
Policy scheduleOwner and Beneficiary As named in the Application or as later changed. See the Owner and Beneficiary Section of the Policy. Policy Number Specimen Policy Date Date of Issue Maturity Date* October 1, 1993 October 1, 1993 October 1, 2058 Policy Loan Interest Rate Death Benefit Option

Related to Policy schedule

  • Policy Statement The RSU Award grant the Company is making under the Plan is unilateral and discretionary and, therefore, the Company reserves the absolute right to amend it and discontinue it at any time without any liability. The Company, with registered offices at Xxx Xxxxxx Xxxxxxxxx, #00-00, Xxxxxxxxx 000000, is solely responsible for the administration of the Plan, and participation in the Plan and the grant of the RSU Award do not, in any way, establish an employment relationship between the Participant and the Company since he or she is participating in the Plan on a wholly commercial basis and the sole employer is Availmed Servicios S.A. de C.V., Grupo Flextronics S.A. de C.V., Flextronics Servicios Guadalajara S.A. de C.V., Flextronics Servicios Mexico S. de X.X. de C.V. and Flextronics Aguascalientes Servicios S.A. de C.V., nor does it establish any rights between the Participant and the Employer. Plan Document Acknowledgment. By accepting the RSU Award, the Participant acknowledges that he or she has received copies of the Plan, has reviewed the Plan and the Agreement in their entirety, and fully understands and accepts all provisions of the Plan and the Agreement. In addition, the Participant further acknowledges that he or she has read and specifically and expressly approves the terms and conditions in the Nature of Grant section of the Agreement, in which the following is clearly described and established: (i) participation in the Plan does not constitute an acquired right; (ii) the Plan and participation in the Plan is offered by the Company on a wholly discretionary basis; (iii) participation in the Plan is voluntary; and (iv) the Company and any Parent, Subsidiary or Affiliates are not responsible for any decrease in the value of the Shares acquired upon vesting of the RSU Award. Finally, the Participant hereby declares that he or she does not reserve any action or right to bring any claim against the Company for any compensation or damages as a result of his or her participation in the Plan and therefore grants a full and broad release to the Employer, the Company and any Parent, Subsidiary or Affiliates with respect to any claim that may arise under the Plan.

  • Umbrella Policies Contractor may satisfy basic coverage limits through any combination of basic coverage and umbrella insurance.

  • Policy Because the volume of human genomic and phenotypic data maintained in these repositories is substantial and, in some instances, potentially sensitive (e.g., data related to the presence or risk of developing particular diseases or conditions and information regarding family relationships or ancestry), data must be shared in a manner consistent with the research participants’ informed consent, and the confidentiality of the data and the privacy of participants must be protected. Access to human genomic data will be provided to research investigators who, along with their institutions, have certified their agreement with the expectations and terms of access detailed below. NIH expects that, through Data Access Request (DAR) process, approved users of controlled-access datasets recognize any restrictions on data use established by the Submitting Institutions through the Institutional Certification, and as stated on the dbGaP study page. Definitions of the underlined terminology in this document are found in section 13. The parties to this Agreement include: the Principal Investigator (PI) requesting access to the genomic study dataset (an “Approved User”), the PI’s home institution (the “Requester”) as represented by the Institutional Signing Official designated through the eRA Commons system, and the NIH. The effective date of this Agreement shall be the DAR Approval Date, as specified in the notification of approval of the Data Access Committee (DAC).